Flowflex Covid-19 Home Antigen Test (1/bx)
Flowflex Covid-19 Home Antigen Test (1/bx)
  • Load image into Gallery viewer, Flowflex Covid-19 Home Antigen Test (1/bx)
  • Load image into Gallery viewer, Flowflex Covid-19 Home Antigen Test (1/bx)

Flowflex Covid-19 Home Antigen Test (1/bx)

$10.99
$10.99
$16.00
Sold out
Shipping calculated at checkout.
Description

Flowflex COVID-19 Home Test, FDA authorized Antigen test that requires only 1 test, results in 15 minutes, Nasal Swab.

  • No Prescription Required - Authorized under FDA EUA, for home use.
  • Detects Active COVID-19 Infection Antigens indicate active disease, find out if you have COVID-19 by performing a painless nasal swab.
  • Test once, unlike other tests, no need to retest a couple of days after the 1st test, unless new symptoms appear!
  • The Flowflex COVID-19 Home Test has been authorized to test patients with or without COVID-19 symptoms.
  • Quick Get Results in 15 minutes. Straightforward and easy to read
  • FSA / HSA ELIGIBLE and reimbursable through insurance! 
Virtual Testing for Lab Documentation

Health Rover provides virtual, self administered tests via televisit in the case you need lab documentation for back to work, back to school or travels. Contact Us to schedule your virtual visit with Health Rover.

Insurance Reimbursement Instructions 

If you purchase an over-the-counter COVID-19 test from a pharmacy, store, or online retailer and are charged for your test, keep your receipt and submit a claim to your insurance company for reimbursement. If your plan has not set up a network of preferred stores, pharmacies, and online retailers at which you can obtain a test with no out-of-pocket expense, you will be reimbursed the amount of the cost of the test. For example, if you buy a two-pack of tests for $34, the plan or insurer would reimburse $34. 

Click here to view the CMS instructions for reimbursement instructions!

EUA Notice
This product has not been FDA cleared or approved but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens.  The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.
Flowflex EUA link